Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

4.35
Delayed Data
As of 9:38am ET
 +0.08 / +1.87%
Today’s Change
3.18
Today|||52-Week Range
4.97
+17.57%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close4.27
Today’s open4.29
Day’s range4.28 - 4.36
Volume4,537
Average volume (3 months)354,688
Market cap$215.9M
Data as of 9:38am ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+60.58%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.03+1.01%
ARWRArrowhead Pharmaceut...+0.28+4.45%
CDXSCodexis Inc-0.10-1.16%
BCLIBrainstorm Cell Ther...+0.03+0.84%
Data as of 9:54am ET, 01/22/2018

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts